Evidence map›Paper›PMID 29437282›Full record

ArticleTraffic (Copenhagen, Denmark)2018

Phagocytosis of antibody-opsonized tumor cells leads to the formation of a discrete vacuolar compartment in macrophages.

Ramraj Velmurugan, Sreevidhya Ramakrishnan, Mingin Kim, Raimund J Ober, E Sally Ward

Open access · hybridAbstract read
In one paragraph

Article in Traffic (Copenhagen, Denmark), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ramraj VelmuruganDepartment of Molecular and Cellular Medicine, Texas A&M University Health Science Center, College Station, Texas.
Sreevidhya RamakrishnanDepartment of Molecular and Cellular Medicine, Texas A&M University Health Science Center, College Station, Texas.
Mingin KimMedical Science Graduate Program, Texas A&M University Health Science Center, College Station, Texas.
Raimund J OberDepartment of Molecular and Cellular Medicine, Texas A&M University Health Science Center, College Station, Texas.
E Sally WardDepartment of Molecular and Cellular Medicine, Texas A&M University Health Science Center, College Station, Texas.ORCID 0000-0002-9311-8571
Texas A&M Health Science Center · US

Funding

High accuracy quantum dot tracking in live cellsR01GM085575 · NIGMS · UNIVERSITY OF TEXAS DALLAS · PI OBER, RAIMUND J · 2008 to 2016
$2.5M
NIGMS NIH HHS R01 GM085575
6 · The paper itself

Abstract

Despite the rapidly expanding use of antibody-based therapeutics to treat cancer, knowledge of the cellular processes following phagocytosis of antibody-opsonized tumor cells is limited. Here we report the formation of a phagosome-associated vacuole that is observed in macrophages as these degradative compartments mature following phagocytosis of HER2-positive cancer cells in the presence of the HER2-specific antibody, trastuzumab. We demonstrate that this vacuole is a distinct organelle that is closely apposed to the phagosome. Furthermore, the size of the phagosome-associated vacuole is increased by inhibition of the mTOR pathway. Collectively, the identification of this vacuolar compartment has implications for understanding the subcellular trafficking processes leading to the destruction of phagocytosed, antibody-opsonized cancer cells by macrophages.

Indexed as

AnimalsAntibodiesHumansLysosomesMacrophagesMembrane FusionMiceNeoplasmsPhagocytosisPhagosomesReceptors, IgGVacuolesAntibodiesReceptors, IgGantibodieslysosomemacrophagesphagosomevacuole

Identifiers

PMID29437282
PMCPMC5869154
OpenAlexW2789804604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.